Christine Murray
Algemeen Adviseur bij CYTOKINETICS, INCORPORATED
Actieve functies van Christine Murray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CYTOKINETICS, INCORPORATED | Algemeen Adviseur | 01-04-2023 | - |
Loopbaan van Christine Murray
Eerdere bekende functies van Christine Murray
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Directeur/Bestuurslid | 07-01-2019 | 15-03-2024 |
Independent Dir/Board Member | 07-01-2019 | 15-03-2024 | |
ULTRAGENYX PHARMACEUTICAL INC. | Algemeen Adviseur | 01-07-2018 | 01-09-2021 |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Corporate Officer/Principal | 01-01-2015 | 01-02-2017 |
RAPTOR PHARMACEUTICAL CORP | Algemeen Adviseur | 01-03-2015 | 01-01-2017 |
ACHAOGEN | Algemeen Adviseur | 01-08-2011 | 02-01-2015 |
Opleiding van Christine Murray
The University of Liverpool | Undergraduate Degree |
Newcastle University | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Verenigd Koninkrijk | 3 |
Operationeel
General Counsel | 4 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
CYTOKINETICS, INCORPORATED | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Horizon Pharmaceutical LLC engages in the development of transformative treatments for people affected by rare and debilitating diseases. It offers PROCYSBI, a delayed-release capsule, which is used for the management of nephropathic cystinosis in adults and for six years and older children. The company was founded by Christopher M. Starr and Todd C. Zankel on April 29, 2002 and is headquartered in Novato, CA. | Health Technology |
Raptor Pharmaceuticals, Inc.
Raptor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Raptor Pharmaceuticals, Inc. operates as a biopharmaceutical company which develops and markets life-altering therapeutics. The company is headquartered in Novato, CA. | Health Technology |
- Beurs
- Insiders
- Christine Murray
- Ervaring